| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC0104 |
| Trial ID | NCT01245387 |
| Disease | Macular Degeneration | Age-Related Macular Degeneration |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Target gene |
| Therapy | Aptamer |
| Treatment | Macugen|pegaptanib|EYE001 |
| Recruitment status | Completed |
| Title | Long-Term Non-Interventional Study (AB Study) To Investigate The Efficacy And Safety Of Macugen In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice |
| Year | 2006 |
| Country | United States |
| Company sponsor | Pfizer |
| Other ID(s) | A5751021 |
| Cohort 1 | |||||||||||
|
|||||||||||